|
PART
|
96T
|
48T
|
STORAGE
|
|
Pre-Coated Plate
|
8×12
|
8×6
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Standards
|
2 vials
|
1 vial
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Biotinylated Antibody (1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Conjugate(1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Antibody Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Standard Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Sample Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Washing Buffer (1:25)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent A
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent B
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent C
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Manual
|
1 set
|
1 set
|
RT
|
Place collected whole blood in refrigerator at 4 ℃ overnight. Then centrifuge for 10mins at 1000-3000 rpm. Take supernatant and either test immediately or place samples at -20 ℃/-80 ℃(1-3 months) for storage.
Take plasma where EDTA, sodium citrate, or heparin has been added as anticoagulant. Mix well. Centrifuge mixture for 10mins at 1000-3000 rpm. Take supernatant and test immediately or place samples at -20 ℃ /-80 ℃ (1-3 months) for storage.
Take tissue slices which have been washed in 0.01 M PBS and then a tissue protein extraction reagent has been added according to proportion of 1 g to 5-10 mL and then mixed on ice bath. After sufficient homogenization, please then centrifuge for 10mins at 5000-10000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10 mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
|
TYPICAL DATA
|
Reference STD1
|
Reference STD2
|
Reference STD3
|
Reference STD4
|
Reference STD5
|
Reference STD6
|
Reference STD7
|
Reference STD8
|
|
Factor-VIII RA, ng/mL
|
10
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0
|
|
Factor-VIII RA, OD.
|
2.3
|
1.278
|
0.71
|
0.394
|
0.219
|
0.122
|
0.068
|
0.045
|
|
Fibrin, ng/mL
|
50
|
25
|
12.5
|
6.25
|
3.125
|
1.563
|
0.781
|
0
|
|
Fibrin, OD.
|
2.393
|
1.329
|
0.739
|
0.41
|
0.228
|
0.127
|
0.07
|
0.047
|
|
PL/Fbn, ng/mL
|
50
|
25
|
12.5
|
6.25
|
3.125
|
1.563
|
0.781
|
0
|
|
PL/Fbn, OD.
|
2.286
|
1.27
|
0.706
|
0.392
|
0.218
|
0.121
|
0.067
|
0.045
|
|
FPA, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
FPA, OD.
|
3.059
|
1.699
|
0.944
|
0.525
|
0.291
|
0.162
|
0.09
|
0.06
|
STANDARD CURVE
To assess linearity of the assay, samples were spiked with high concentrations of Human Factor-VIII RA, Fibrin, PL/Fbn, FPA and diluted with the appropriate calibrator diluent to produce samples with values within the dynamic range of the assay.
|
Matrix
|
Scope %
|
Average % Recovery Rate
|
|
serum(n=5)
|
81-93
|
87
|
|
EDTA plasma(n=5)
|
89-101
|
95
|
|
Cell Culture Media(n=5)
|
95-105
|
100
|
|
Within-Run Precision
|
Inter-Batch Precision
|
|||||
|
Sample
|
1
|
2
|
3
|
1
|
2
|
3
|
|
n
|
20
|
20
|
20
|
20
|
20
|
20
|
|
CV%
|
6.1
|
6.5
|
6.2
|
7.7
|
8.1
|
7.7
|